Kapate Neha, Clegg John R, Mitragotri Samir
Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA.
John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA.
Adv Drug Deliv Rev. 2021 Oct;177:113807. doi: 10.1016/j.addr.2021.05.017. Epub 2021 May 21.
Shape of particulate drug carries has been identified as a key parameter in determining their biological outcome. In this review, we analyze the field of particle shape as it shifts from fundamental investigations to contemporary applications for disease treatment, while highlighting outstanding remaining questions. We summarize fabrication and characterization methods and discuss in depth how particle shape influences biological interactions with cells, transport in the vasculature, targeting in the body, and modulation of the immune response. As the field moves from discoveries to applications, further attention needs to be paid to factors such as characterization and quality control, selection of model organisms, and disease models. Taken together, these aspects will provide a conceptual foundation for designing future non-spherical drug carriers to overcome biological barriers and improve therapeutic efficacy.
颗粒药物载体的形状已被确定为决定其生物学结果的关键参数。在本综述中,我们分析了颗粒形状领域,该领域正从基础研究转向疾病治疗的当代应用,同时突出了仍未解决的重要问题。我们总结了制备和表征方法,并深入讨论了颗粒形状如何影响与细胞的生物相互作用、在脉管系统中的运输、在体内的靶向以及免疫反应的调节。随着该领域从发现走向应用,需要进一步关注诸如表征和质量控制、模式生物的选择以及疾病模型等因素。综上所述,这些方面将为设计未来的非球形药物载体以克服生物屏障并提高治疗效果提供概念基础。